185 related articles for article (PubMed ID: 7474675)
1. "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.
Toto RD; Mitchell HC; Smith RD; Lee HC; McIntire D; Pettinger WA
Kidney Int; 1995 Sep; 48(3):851-9. PubMed ID: 7474675
[TBL] [Abstract][Full Text] [Related]
2. Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.
Pettinger WA; Lee HC; Reisch J; Mitchell HC
Hypertension; 1989 Jun; 13(6 Pt 2):766-72. PubMed ID: 2544523
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
[TBL] [Abstract][Full Text] [Related]
4. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
5. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
[TBL] [Abstract][Full Text] [Related]
6. Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
Chen Y; Lipkowitz MS; Salem RM; Fung MM; Bhatnagar V; Mahata M; Nievergelt CM; Rao F; Mahata SK; Schork NJ; Hicks PJ; Bowden DW; Freedman BI; Brophy VH; O'Connor DT;
Am J Nephrol; 2010; 32(1):23-30. PubMed ID: 20484896
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.
Lewis J; Agodoa L; Cheek D; Greene T; Middleton J; O'Connor D; Ojo A; Phillips R; Sika M; Wright J;
Am J Kidney Dis; 2001 Oct; 38(4):744-53. PubMed ID: 11576877
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Toto RD; Kirk KA; Coresh J; Jones C; Appel L; Wright J; Campese V; Olutade B; Agodoa L
J Am Soc Nephrol; 1997 Feb; 8(2):279-87. PubMed ID: 9048347
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.
Fogo A; Breyer JA; Smith MC; Cleveland WH; Agodoa L; Kirk KA; Glassock R
Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
[TBL] [Abstract][Full Text] [Related]
12. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
Hebert LA; Kusek JW; Greene T; Agodoa LY; Jones CA; Levey AS; Breyer JA; Faubert P; Rolin HA; Wang SR
Hypertension; 1997 Sep; 30(3 Pt 1):428-35. PubMed ID: 9314428
[TBL] [Abstract][Full Text] [Related]
14. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
Obialo CI; Hewan-Lowe K
J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.
Buckalew VM; Berg RL; Wang SR; Porush JG; Rauch S; Schulman G
Am J Kidney Dis; 1996 Dec; 28(6):811-21. PubMed ID: 8957032
[TBL] [Abstract][Full Text] [Related]
16. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
Lewis J; Greene T; Appel L; Contreras G; Douglas J; Lash J; Toto R; Van Lente F; Wang X; Wright JT;
J Am Soc Nephrol; 2004 Dec; 15(12):3175-83. PubMed ID: 15579521
[TBL] [Abstract][Full Text] [Related]
17. Hyperfiltration and conservation of renal function in hypertensive nephrosclerosis patients.
Lee HC; Mitchell HC; Van Dreal P; Pettinger WA
Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):68-74. PubMed ID: 8465839
[TBL] [Abstract][Full Text] [Related]
18. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
[TBL] [Abstract][Full Text] [Related]
19. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
[TBL] [Abstract][Full Text] [Related]
20. Common charge-shift mutation Glu65Lys in K+ channel β₁-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease.
Chen Y; Salem RM; Rao F; Fung MM; Bhatnagar V; Pandey B; Mahata M; Waalen J; Nievergelt CM; Lipkowitz MS; Hamilton BA; Mahata SK; O'Connor DT
Am J Nephrol; 2010; 32(5):414-24. PubMed ID: 20861615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
